ReviewJournal of clinical and translational hepatology2024

Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease.

Ye Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.